Birch Financial Group’s Ascendis Pharma A/S ASND Stock Holding History

Birch Financial Group’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$222K	Sell	976 -17	-2%	-$4.31K	0.1%	122
2026 Q2	$265K	Sell	993 -66	-6%	-$15.4K	0.14%	111
2026 Q1	$242K	Buy	1,059 +9	+0.9%	+$2.02K	0.14%	115
2025 Q4	$224K	Sell	1,050 -247	-19%	-$51K	0.13%	123
2025 Q3	$258K	Sell	1,297 -60	-4%	-$11.2K	0.15%	100
2025 Q2	$234K	Sell	1,357 -138	-9%	-$22.5K	0.19%	99
2025 Q1	$233K	Sell	1,495 -44	-3%	-$6.28K	0.21%	90
2024 Q4	$212K	Buy	+1,539	New	+$202K	0.24%	80

Other funds holding ASND

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

ARS Investment Partners New York $2.23B AUM 74.02% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

USS Investment Management London, United Kingdom $25.1B AUM 30.53% 1-Year Est. Return

Birch Financial Group's ASND Position: Q3 2026 in Review

Birch Financial Group reduced its Ascendis Pharma A/S (ASND) stake by 1.7% in Q3 2026, selling an estimated $4.31K and leaving 976 shares worth $222K. The position accounts for 0.1% of the portfolio, ranked #122.

Birch Financial Group first reported a position in ASND in Q4 2024 and has held it in 8 quarters since. The position peaked at $265K in Q2 2026. 156 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

Birch Financial Group held 976 shares of Ascendis Pharma A/S worth $222K as of Q3 2026.
Birch Financial Group sold 17 Ascendis Pharma A/S shares in Q3 2026, an estimated $4.31K.
Ascendis Pharma A/S made up 0.1% of Birch Financial Group's portfolio in Q3 2026, its #122 holding.
Birch Financial Group first reported a position in Ascendis Pharma A/S in Q4 2024 and has held it in 8 quarters since.
Birch Financial Group's Ascendis Pharma A/S position peaked at $265K in Q2 2026.
156 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on Birch Financial Group's 13F filing for Q3 2026, filed 27 Oct 2026.